20 results
PRE 14A
ALLO
Allogene Therapeutics Inc
14 Apr 22
Preliminary proxy
4:10pm
. Messemer each qualify as an “audit committee financial expert,” as defined in applicable SEC rules. The Board made a qualitative assessment of each of Dr
DEF 14A
msy4 uznoh
24 Apr 19
Definitive proxy
8:01am
10-K
EX-10.17
exzd5n7jceuquk704
8 Mar 19
Annual report
4:02pm
10-K
EX-10.18
umkf2wve
8 Mar 19
Annual report
4:02pm
424B4
3d6kua1r4s7f
11 Oct 18
Prospectus supplement with pricing info
5:24pm
DRS
nlnf1um
10 Aug 18
Draft registration statement
12:00am
DRS
EX-10.11
gjj984
10 Aug 18
Draft registration statement
12:00am
- Prev
- 1
- Next